USP7 and neoplasm: As for Lewis lung carcinoma mice, treatment with the USP7 inhibitor weakened the tumor growth as well as increased the infiltration of M1 macrophages and CD8 + T cells expressing IFN-γ through the mechanism underlying activating the p38 mitogen-activated protein kinase (MAPK) pathway.